InvestorsHub Logo
Followers 215
Posts 15842
Boards Moderated 7
Alias Born 06/02/2007

Re: Hungry_Ghost post# 392206

Wednesday, 08/10/2022 12:08:26 PM

Wednesday, August 10, 2022 12:08:26 PM

Post# of 402365
"That’s why they only approved gasping for breath, barely warm corpses to be used in the trial."

I've seen that claim before, however we know it's complete bullshit from IPIX' own press release:

"There was also no difference in mortality between active and placebo, with both groups experiencing low mortality rates (7 percent)"

http://www.ipharminc.com/press-release/2022/3/7/innovation-pharmaceuticals-reports-additional-findings-based-on-review-of-brilacidin-phase-2-covid-19-trial-results-and-compassionate-use-cases

The fact that 93% of all patients survived (irrespective of whether they received brilacidin or not) speaks to the fact that these patients were more on the moderate end of the scale rather than severe, and to the efficacy of standard of care (primarily remdesivir and dexamethasone, I imagine).

Certainly not "barely warm corpses"!

“The saddest lessons of history is this: If we’ve been conned long enough, we reject any evidence of the con. It’s too painful to acknowledge, even to ourselves, that we’ve been taken. if you give a charlatan power over you, you never get it back.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News